Home > > > > Report Detail

Global Pain Management Drugs Market Forecast 2019-2027

Publisher Name :
Date: 10-Dec-2018
No. of pages: 134

KEY FINDINGS

Pain is a distressing sensory and emotional feeling that occurs due to tissue damage or illness that can take place for short-term (acute pain) to long-term (chronic pain). Pain management drugs market supplies medications and therapies which upon employs an interdisciplinary approach for easing the suffering and improving the quality of life of such victims or patients. The global market for pain management drugs is escalating at 3.88% CAGR during the forecast period of 2019-2027. The market has been valued $ XX millions in its base year of 2018 and is expected to reach an astounding sum of $ XX millions by the end of the forecast period, essentially, 2027.

MARKET INSIGHTS

The factors that are the sole drivers for the growth of the pain management drugs market are the public demand for medications with fewer side-effects and their consequential availability, and the rise in global geriatric population that could increase the use of pain medications are expected to drive the global market for pain management drugs. Alongside these circumstances, with the advancement in technology, there are researchers who are trying to develop abuse-deterrent drugs due to the increase in the number of drug abuse cases globally. This can pave way for the entry of newer drugs for the said market. Patent expiration of pain relieving drugs can decrease their market value, leading to the decrease in revenue earned for the global market. This can potentially affect the market growth.

REGIONAL INSIGHTS

The global pain management drugs market has been segmented on the basis of several region regions, which are the North America, Europe, Asia-Pacific and the collective countries from the Rest of the World. North America holds the largest share by revenue $ XX millions in the year 2018. This is attributable to the fact that this region has a large number of aging inhabitants and favorable regulatory conditions.

But conversely, Asia-Pacific region has the fastest growing market for pain management drugs.

Global Pain Management Drugs Market Forecast 2019-2027

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Opioids Market Holds The Largest Market Share In Terms Of Drug Class
3.2.2. Cancer Pain Indication Is Anticipated To Grow At A Significant Rate
4. Market Dynamics
4.1. Market Scope & Definition
4.2. Market Drivers
4.2.1. Growth In The Incidence And Prevalence Of Chronic Diseases
4.2.2. The Rise In Awareness Regarding The Side-Effects Of Pain Medication
4.2.3. Rise In Geriatric Population
4.3. Market Restraints
4.3.1. Accessibility Of Alternative Therapies
4.3.2. Increase In Drug Mistreatment
4.4. Market Opportunities
4.4.1. Technological Advancement
4.4.2. Growth Potential In Untapped Economies
4.5. Market Challenges
4.5.1. Patent Expiration
5. Market By Drug Class
5.1. Nsaids
5.2. Anesthetics
5.3. Anticonvulsants
5.4. Anti-Migraine Agents
5.5. Antidepressants
5.6. Opioids
5.7. Non-Narcotic Analgesics
6. Market By Indication
6.1. Arthritic Pain
6.2. Neuropathic Pain
6.3. Cancer Pain
6.4. Chronic Back Pain
6.5. Post-Operative Pain
6.6. Migraine
6.7. Fibromyalgia
7. Key Analytics
7.1. Porter's Five Force Model
7.1.1. Threat Of New Entrants
7.1.2. Threat Of Substitute
7.1.3. Bargaining Power Of Suppliers
7.1.4. Bargaining Power Of Buyers
7.1.5. Threat Of Competitive Rivalry
7.2. Regulatory Framework
7.3. Opportunity Matrix
7.4. Value Chain Analysis
7.5. Vendor Landscape
8. Geographical Analysis
8.1. North America
8.1.1. The United States
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. The United Kingdom
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest Of Europe
8.3. Asia-Pacific
8.3.1. Japan
8.3.2. China
8.3.3. India
8.3.4. Australia
8.3.5. South Korea
8.3.6. Rest Of Asia-Pacific
8.4. Rest Of World
8.4.1. Latin America
8.4.2. Middle East And Africa
9. Competitive Landscape
9.1. Market Share Analysis
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Company Overview
9.2.1.2. Product Portfolio
9.2.1.3. Scot Analysis
9.2.1.4. Strategic Initiatives
9.2.2. Acura Pharmaceuticals, Inc.
9.2.2.1. Company Overview
9.2.2.2. Product Portfolio
9.2.2.3. Strategic Initiatives
9.2.3. Cipher Pharmaceuticals Inc.
9.2.3.1. Company Profiles
9.2.3.2. Product Portfolio
9.2.3.3. Strategic Initiatives
9.2.4. Daiichi Sankyo, Inc.
9.2.4.1. Company Overview
9.2.4.2. Product Portfolio
9.2.4.3. Strategic Initiatives
9.2.5. Egalet Corp.
9.2.5.1. Company Overview
9.2.5.2. Product Portfolio
9.2.5.3. Strategic Initiatives
9.2.6. Eli Lilly And Company
9.2.6.1. Company Overview
9.2.6.2. Product Portfolio
9.2.6.3. Scot Analysis
9.2.6.4. Strategic Initiatives
9.2.7. Glaxosmithkline
9.2.7.1. Company Overview
9.2.7.2. Product Portfolio
9.2.7.3. Scot Analysis
9.2.7.4. Strategic Initiatives
9.2.8. Hikma Pharmaceuticals Plc
9.2.8.1. Company Overview
9.2.8.2. Product Portfolio
9.2.8.3. Strategic Initiatives
9.2.9. Johnson & Johnson
9.2.9.1. Company Overview
9.2.9.2. Product Portfolio
9.2.9.3. Scot Analysis
9.2.9.4. Strategic Initiatives
9.2.10. Lupin Ltd.
9.2.10.1. Company Overview
9.2.10.2. Product Portfolio
9.2.10.3. Strategic Initiatives
9.2.11. Pfizer, Inc.
9.2.11.1. Company Profiles
9.2.11.2. Product Portfolio
9.2.11.3. Scot Analysis
9.2.11.4. Strategic Initiatives
9.2.12. Purdue Pharma L.P.
9.2.12.1. Company Overview
9.2.12.2. Product Portfolio
9.2.12.3. Strategic Initiatives
9.2.13. Merck & Co., Inc.
9.2.13.1. Company Profiles
9.2.13.2. Product Portfolio
9.2.13.3. Scot Analysis
9.2.13.4. Strategic Initiatives
9.2.14. Novartis
9.2.14.1. Company Overview
9.2.14.2. Product Portfolio
9.2.14.3. Scot Analysis
9.2.14.4. Strategic Initiatives
9.2.15. Insys Therapeutics, Inc.
9.2.15.1. Company Overview
9.2.15.2. Product Portfolio
9.2.15.3. Strategic Initiatives

List Of Tables

Table 1 Global Pain Management Drugs Market By Region 2019-2027 ($ Million)
Table 2 Global Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 3 Global Nsaids Market By Region 2019-2027 ($ Million)
Table 4 Global Anesthetics Market By Region 2019-2027 ($ Million)
Table 5 Global Anticonvulsants Market By Region 2019-2027 ($ Million)
Table 6 Global Anti-Migraine Agents Market By Region 2019-2027 ($ Million)
Table 7 Global Antidepressants Market By Region 2019-2027 ($ Million)
Table 8 Global Opioids Market By Region 2019-2027 ($ Million)
Table 9 Global Non-Narcotic Analgesics Market By Region 2019-2027 ($ Million)
Table 10 Global Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 11 Global Arthritic Pain Market By Region 2019-2027 ($ Million)
Table 12 Global Neuropathic Pain Market By Region 2019-2027 ($ Million)
Table 13 Global Cancer Pain Market By Region 2019-2027 ($ Million)
Table 14 Global Chronic Back Pain Market By Region 2019-2027 ($ Million)
Table 15 Global Post-Operative Pain Market By Region 2019-2027 ($ Million)
Table 16 Global Migraine Market By Region 2019-2027 ($ Million)
Table 17 Global Fibromyalgia Market By Region 2019-2027 ($ Million)
Table 18 Global Pain Management Drugs Market By Region 2019-2027 ($ Million)
Table 19 North America Pain Management Drugs Market By Country 2019-2027 ($ Million)
Table 20 The United States Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 21 The United States Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 22 Canada Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 23 Canada Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 24 Europe Pain Management Drugs Market By Country 2019-2027 ($ Million)
Table 25 Germany Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 26 Germany Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 27 France Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 28 France Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 29 The United Kingdom Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 30 The United Kingdom Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 31 Italy Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 32 Italy Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 33 Spain Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 34 Spain Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 35 Asia-Pacific Pain Management Drugs Market By Country 2019-2027 ($ Million)
Table 36 Japan Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 37 Japan Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 38 China Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 39 China Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 40 India Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 41 India Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 42 Australia Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 43 Australia Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 44 South Korea Pain Management Drugs Market By Drug Class 2019-2027 ($ Million)
Table 45 South Korea Pain Management Drugs Market By Indication 2019-2027 ($ Million)
Table 46 Rest Of World Pain Management Drugs Market By Country 2019-2027 ($ Million)



List Of Figures

Figure 1 Global Pain Management Drugs Market 2019-2027 ($ Million)
Figure 2 Global Pain Management Drugs Market Share By Drug Class 2018 & 2027 (%)
Figure 3 Global Pain Management Drugs Market By Nsaids 2019-2027 ($ Million)
Figure 4 Global Pain Management Drugs Market By Anesthetics 2019-2027 ($ Million)
Figure 5 Global Pain Management Drugs Market By Anticonvulsants 2019-2027 ($ Million)
Figure 6 Global Pain Management Drugs Market By Anti-Migraine Agents 2019-2027 ($ Million)
Figure 7 Global Pain Management Drugs Market By Antidepressants 2019-2027 ($ Million)
Figure 8 Global Pain Management Drugs Market By Opioids 2019-2027 ($ Million)
Figure 9 Global Pain Management Drugs Market By Non-Narcotic Analgesics 2019-2027 ($ Million)
Figure 10 Global Pain Management Drugs Market Share By Indication 2018 & 2027 (%)
Figure 11 Global Pain Management Drugs Market By Arthritic Pain 2019-2027 ($ Million)
Figure 12 Global Pain Management Drugs Market By Neuropathic Pain 2019-2027 ($ Million)
Figure 13 Global Pain Management Drugs Market By Cancer Pain 2019-2027 ($ Million)
Figure 14 Global Pain Management Drugs Market By Chronic Back Pain 2019-2027 ($ Million)
Figure 15 Global Pain Management Drugs Market By Post-Operative Pain 2019-2027 ($ Million)
Figure 16 Global Pain Management Drugs Market By Migraine 2019-2027 ($ Million)
Figure 17 Global Pain Management Drugs Market By Fibromyalgia 2019-2027 ($ Million)
Figure 18 Porter's Five Force Model
Figure 19 Global Pain Management Drugs Market Regional Outlook 2018 & 2027 (%)
Figure 20 The United States Pain Management Drugs Market 2019-2027 ($ Million)
Figure 21 Canada Pain Management Drugs Market 2019-2027 ($ Million)
Figure 22 Germany Pain Management Drugs Market 2019-2027 ($ Million)
Figure 23 France Pain Management Drugs Market 2019-2027 ($ Million)
Figure 24 The United Kingdom Pain Management Drugs Market 2019-2027 ($ Million)
Figure 25 Italy Pain Management Drugs Market 2019-2027 ($ Million)
Figure 26 Spain Pain Management Drugs Market 2019-2027 ($ Million)
Figure 27 Rest Of Europe Pain Management Drugs Market 2019-2027 ($ Million)
Figure 28 Japan Pain Management Drugs Market 2019-2027 ($ Million)
Figure 29 China Pain Management Drugs Market 2019-2027 ($ Million)
Figure 30 India Pain Management Drugs Market 2019-2027 ($ Million)
Figure 31 Australia Pain Management Drugs Market 2019-2027 ($ Million)
Figure 32 South Korea Pain Management Drugs Market 2019-2027 ($ Million)
Figure 33 Rest Of Asia-Pacific Pain Management Drugs Market 2019-2027 ($ Million)
Figure 34 Latin America Pain Management Drugs Market 2019-2027 ($ Million)
Figure 35 Middle East And Africa Pain Management Drugs Market 2019-2027 ($ Million)
Figure 36 Pain Management Market Share Analysis 2017 (%)
  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs